Tetraspanin 1 (TSPAN1) promotes growth and transferation of breast cancer cells via mediating PI3K/Akt pathway

References

• Aydin A, Gursoy A. Lymphedema information and prevention practices of women after breast cancer surgery. Florence Nightingale J Nurs. 2020; 28(3):350–358. PMID: 34263214.
   PubMedGoogle Scholar
• Ross JS, Linette GP, Stec J, et al. Breast cancer biomarkers and molecular medicine. Expert Rev Mol Diagn. 2003;3(5):573–585. PMID: 14510178.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang C, Guan J, et al. Progress of Breast Cancer basic research in China. Int J Biol Sci. 2021;17(8):2069–2079. PMID: 34131406.
   PubMed Web of Science ®Google Scholar
• Nicolini A, Ferrari P, Duffy MJ. Prognostic and predictive biomarkers in breast cancer: past, present and future. Semin Cancer Biol. 2018;52(Pt1):56–73. PMID: 28882552.
   PubMedGoogle Scholar
• Chang AY, Most C, Pandya KJ. Continuous intravenous infusion of 5-fluorouracil in the treatment of refractory breast cancer. Am J Clin Oncol. 1989;12(5):453–455. PMID: 2801607.
   PubMed Web of Science ®Google Scholar
• Shi Y, Tan SH, Ng S, et al. Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy. Autophagy. 2015;11(5):769–784. PMID: 25945613.
   PubMed Web of Science ®Google Scholar
• Chila G, Guarini V, Galizia D, et al. The clinical efficacy and safety of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer. Drug Des Devel Ther. 2021;15:2711–2720. PMID: 34188449.
   PubMed Web of Science ®Google Scholar
• Jeong H, Jeong JH, Kim JE, et al. Comparison of the effectiveness and clinical outcome of everolimus followed by CDK4/6 inhibitors with the opposite treatment sequence in hormone receptor-positive, HER2-negative metastatic breast cancer. Cancer Res Treat. 2021; PMID: 34176251. doi:10.4143/crt.2021.205
   Web of Science ®Google Scholar
• Wang R, Yang H, Khan AR, et al. Redox-responsive hyaluronic acid-based nanoparticles for targeted photodynamic therapy/chemotherapy against breast cancer. J Colloid Interface Sci. 2021;598:213–228. PMID: 33901847.
   PubMed Web of Science ®Google Scholar
• Iwai K, Ishii M, Ohshima S, et al. Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis. Allergol Int. 2007;56(4):457–463. PMID: 17965585.
   PubMedGoogle Scholar
• Liu L, He B, Liu WM, et al. Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem. 2007;282(43):31631–31642. PMID: 17716972.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi G, Gao F, et al. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCgamma. Oncol Rep. 2019;41(4):2117–2125. PMID: 30720116.
   PubMed Web of Science ®Google Scholar
• Richardson MM, Jennings LK, Zhang XA. Tetraspanins and tumor progression. Clin Exp Metastasis. 2011;28(3):261–270. PMID: 21184145.
   PubMed Web of Science ®Google Scholar
• Lu Z, Pang T, Yin X, et al. Delivery of TSPAN1 siRNA by novel Th17 targeted cationic liposomes for gastric cancer intervention. J Pharm Sci. 2020;109(9):2854–2860. PMID: 32497593.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhu YY, Zhang XJ, et al. TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma. World J Gastroenterol. 2009;15(18):2270–2276. PMID: 19437569.
   PubMed Web of Science ®Google Scholar
• Stump RJ, Lovicu FJ, Ang SL, et al. Lithium stabilizes the polarized lens epithelial phenotype and inhibits proliferation, migration, and epithelial mesenchymal transition. J Pathol. 2006;210(2):249–257. PMID: 16924593.
   PubMed Web of Science ®Google Scholar
• Hodorogea A, Calinescu A, Antohe M, et al. Epithelial-mesenchymal transition in skin cancers: a review. Anal Cell Pathol (Amst). 2019;2019:3851576. PMID: 31934531.
   PubMedGoogle Scholar
• Wang Y, Liang Y, Yang G, et al. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling. J Exp Clin Cancer Res. 2018;37(1):300. PMID: 30514341.
   PubMedGoogle Scholar
• Menke CH, Pohlmann PR, Backes A, et al. Tumor size as a surrogate end point for the detection of early breast cancer: a 30-year (1972-2002), single-center experience in southern Brazil. Breast J. 2007;13(5):448–456. PMID: 17760665.
   PubMed Web of Science ®Google Scholar
• Yin P, Bai Y, Wang Z, et al. Non-canonical Fzd7 signaling contributes to breast cancer mesenchymal-like stemness involving Col6a1. Cell Commun Signal. 2020;18(1):143. PMID: 32894152.
   PubMed Web of Science ®Google Scholar
• Noguchi M, Inokuchi M, Noguchi M, et al. Axillary surgery for breast cancer: past, present, and future. Breast Cancer. 2021;28(1):9–15. PMID: 33165758.
   PubMed Web of Science ®Google Scholar
• Garcia-Mayea Y, Mir C, Carballo L, et al. TSPAN1: a novel protein involved in head and neck squamous cell carcinoma chemoresistance. Cancers (Basel). 2020;12(11). PMID: 33167355. DOI:10.3390/cancers12113269
   PubMed Web of Science ®Google Scholar
• Ye H, Li T, Wang H, et al. TSPAN1, TMPRSS4, SDR16C5, and CTSE as novel panel for pancreatic cancer: a bioinformatics analysis and experiments validation. Front Immunol. 2021;12:649551. PMID: 33815409.
   PubMed Web of Science ®Google Scholar
• Wang S, Liu X, Khan AA, et al. miR-216a-mediated upregulation of TSPAN1 contributes to pancreatic cancer progression via transcriptional regulation of ITGA2. Am J Cancer Res. 2020;10(4):1115–1129. PMID: 32368389.
   PubMed Web of Science ®Google Scholar
• Zhou C, Liang Y, Zhou L, et al. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer. Autophagy. 2020:1–21. PMID: 32972302. DOI:10.1080/15548627.2020.1826689
   PubMedGoogle Scholar
• Xu F, Gao Y, Wang Y, et al. Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy. Oncotarget. 2016;7(39):63294–63305. PMID: 27556508.
   PubMedGoogle Scholar
• Chen L, Zhu Y, Li H, et al. Knockdown of TSPAN1 by RNA silencing and antisense technique inhibits proliferation and infiltration of human skin squamous carcinoma cells. Tumori. 2010;96(2):289–295. PMID: 20572588.
   PubMed Web of Science ®Google Scholar
• Wang S, Tong X, Li C, et al. Quaking 5 suppresses TGF-beta-induced EMT and cell invasion in lung adenocarcinoma. EMBO Rep. 2021;22(6):e52079. PMID: 33769671.
   PubMed Web of Science ®Google Scholar
• Pal A, Barrett TF, Paolini R, et al. Partial EMT in head and neck cancer biology: a spectrum instead of a switch. Oncogene. 2021; PMID: 34239045. doi:10.1038/s41388-021-01868-5
   PubMed Web of Science ®Google Scholar
• Ma Z, Lou S, Jiang Z. PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway. Aging (Albany NY). 2020;12(9):7985–8000. PMID: 32385195.
   PubMedGoogle Scholar
• Xu W, Yu M, Qin J, et al. LACTB regulates PIK3R3 to promote autophagy and inhibit EMT and proliferation through the PI3K/AKT/mTOR signaling pathway in colorectal cancer. Cancer Manag Res. 2020;12:5181–5200. PMID: 32636680.
   PubMed Web of Science ®Google Scholar